Exploring Next-Generation Treatment for Major Depressive Disorder with Alzamend Neuro, Inc.

Update: 2024-08-12

Description

Join us as we discuss Alzamend Neuro, Inc.'s partnership with Massachusetts General Hospital for a Phase II trial of a next-generation treatment for Major Depressive Disorder (MDD). Learn about the innovative approach of using AL001, a lithium-based therapeutic candidate, to address the symptoms of MDD. CEO Stephan Jackman shares his optimism for the potential of AL001 as a safer and more effective alternative for MDD treatment. Alzamend Neuro is also actively involved in Phase II trials for bipolar disorder and Alzheimer's disease, with Dr. Ovidiu Andronesi leading the way.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Revolutionizing Drug Discovery with Quantum Computing and Sustainability Showcase at WETEX

2024-10-0302:51

Innovations in Water Sustainability: From Ammonia Production to Fog Harvesting

2024-10-0102:58

Innovations in Sustainability, Cardiovascular Health, and the Mysteries of Electricity

2024-09-2603:52

Innovations in Cancer Treatment and Care Coordination for Children with Trisomy 21

2024-09-1304:24

Cardiovascular Health in Pregnancy and Pain Therapeutics Summit Preview

2024-09-0803:09

Exploring Blood Pressure Management, Longevity Science, and UFO Sightings

2024-09-0507:19

Innovations in Health and Space: PAD Prevention and Texas' Space Vision

2024-09-0403:06

Advancements in Water Resource Forecasting and Uranium Market Resurgence

2024-08-2303:03

The Future of Autonomous Aviation with Horizon Aircraft CEO Brandon Robinson

2024-08-1501:58

Breakthrough in Satellite-Characterization Upgrades and High-Speed Rail Resilience Study

2024-08-1503:09

Exploring Growth Opportunities: Panther Minerals Inc.'s Expansion in the Uranium Market

2024-08-1402:12

Exploring Next-Generation Treatment for Major Depressive Disorder with Alzamend Neuro, Inc.

2024-08-1202:11

Exploring Li-FT Power's Lithium Exploration in Canada with CEO Francis MacDonald

2024-08-0901:39

Revolutionizing Bipolar Disorder Treatment with AL001 and Enhancing Corn Lines with Light Technology

2024-08-0603:58

Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies

2024-08-0102:10

Hope on the Horizon: Promising Treatment for Pancreatic Cancer

2024-07-3102:06

Advancements in Mental Health Treatment and Mineral Exploration Efforts

2024-07-3002:50

Exploring New Horizons: Golden Shield Resources Acquires Tucano Gold & Classiq Launches Qmod

2024-07-2402:51

Mining and Exploration Updates, Clinical Study on Depression, and TechBio Startup Launch

2024-07-1807:46

Mining Stocks Surge, Giant Sequoias Decline, and Copper Exploration Update

2024-07-1604:38

00:00

1.0x

Exploring Next-Generation Treatment for Major Depressive Disorder with Alzamend Neuro, Inc.

#box-pro-ellipsis-173177229623774{-webkit-line-clamp:2;}Exploring Next-Generation Treatment for Major Depressive Disorder with Alzamend Neuro, Inc.

Exploring Next-Generation Treatment for Major Depressive Disorder with Alzamend Neuro, Inc.

NewsRamp

Exploring Next-Generation Treatment for Major Depressive Disorder with Alzamend Neuro, Inc.